The Ralph Wilson Medical Research Foundation is proud to announce the following first year grant and second year grant renewal recipients for the 2006 cycle:

2006 FIRST YEAR GRANTS AWARDED

The Cleveland Clinic Foundation: Saurav Misra, Ph.D., Principal Investigator
Treating Cystic Fibrosis by Inhibition of CFTR Degradation: a Structural and Biochemical Screening Approach  

Mayo Clinic : Michael A. Barry, Ph.D., Principal Investigator
Development of Stem Cell Targeting Ligands for Imaging and Therapeutics

Miami Project:  Vance Lemmon, Ph.D., Principal Investigator
Identification and Testing of Corticospinal Track Regeneration Associated Genes

Roswell Park Cancer Institute: Peter Demant, M.D. Ph.D., Carolyn D. Farrell, M.S, NP-C, CGC, Co- Principal Investigators
Genes Contributing to Increased Risk for Non-Site Specific Cancers - Analysis in Cancer Families

Wayne State University : Jayanth Panyam, Ph.D., Principal Investigator
Nanoparticles for Targeted Drug Delivery to Eliminate Chlamydial Infection

2005 RENEWAL GRANTS AWARDED

Cleveland Clinic: Riquiang Yan, Ph.D. Principal Investigator
The role of RTN3 in the formation of dystrophic neuritis

Mayo Clinic: Vanda A. Lennon, MD, Ph.D., Principal Investigator
Autoimmunity Targeting Water Channels

Miami Project: Daniel J. Liebl, Ph.D., Principal Investigator
Eph receptors are new and novel regulators of cell survival following spinal cord injury

Roswell Park Cancer Institute: Ashwani Rajput, MD, Principal Investigator
Potential Avenues for Extending EGRF Efficacy

University of Michigan: Kenneth Pienta, MD, Shuichi Takayama, Ph.D., Co-Investigators
Utilizing Microfluidics Technology for Characterizing prostata Cancer Stem Cells as a Therapeutic Target to Treat Prostate Cancer

The Ralph Wilson Medical Research Foundation was established in 1999 by Ralph C. Wilson, Jr., and is dedicated to supporting innovative, high risk/high impact biomedical research. The Foundation has contributed over $8,000,000 to the effort since its inception and provides grant funding exclusively to five partner institutions. It is designed to foster novel and innovative research in the areas of cardiovascular diseases, cancer, neurosciences and musculoskeletal disorders. Please see the foundation web site, www.rwmrf.org, for more information.

If you have any questions about this announcement, please contact Mary Owen at the Ralph Wilson Medical Research Foundation at 313-885-5263.